Stay updated on Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T06:07:16.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision notes updated to include v3.4.3 and remove v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T02:29:32.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the site. The prior 3.4.1 notice about government funding and operating status was removed, indicating an update to the page template.
    Difference
    0.4%
    Check dated 2026-02-11T14:13:40.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A government funding status notice was added to the page. The page revision was updated to v3.4.1, replacing the previous v3.4.0 reference.
    Difference
    0.4%
    Check dated 2026-02-04T10:18:18.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The glossary toggle is now available, and a 'Last Update Submitted that Met QC Criteria' label was added in the updates section along with a 'No FEAR Act Data' notice and a revised page version of 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:00:02.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Site revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:26:54.000Z thumbnail image

Stay in the know with updates to Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab Combo in Rare Cancers Clinical Trial page.